CIRM Funded Clinical Trials
The UCLA Delayed Immunological Tolerance after Kidney Transplantation Program
Disease Area:
Kidney Disease
Trial Sponsor:
University of California, Los Angeles
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
